Compare Intercontinental Exchange Inc. Common Stock (ICE) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intercontinental Exchange Inc. Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Intercontinental Exchange Inc. Common Stock trades at $155.35 (market cap $85.66B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: Intercontinental Exchange Inc. Common Stock is far larger — about 50.1× Nuvation Bio Inc. Class A Common Stock's market cap, and Intercontinental Exchange Inc. Common Stock pays a 1.36% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| ICE | NUVB | |
|---|---|---|
Market Cap | $85.66B | $1.71B |
Volume | 1,638,131 | 5,448,712 |
Sector | Financials | Health |
52-Week High | $175.10 | $9.54 |
52-Week Low | $122.91 | $3.41 |
Enterprise Value | $103.57B | $1.30B |
Dividend Yield | 1.36% | — |
Typical Hold Time | — | 0 Days |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Intercontinental Exchange Inc. Common Stock
Intercontinental Exchange provides technology and data services for financial institutions, corporations, and governments. Its businesses include exchanges and clearing, fixed-income data and analytics, and mortgage technology.
Read more on ICE →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
